Neural Mobilization for Reduction of Spasticity in Stroke

August 16, 2022 updated by: Asir John Samuel

Effectiveness of Neural Mobilization on Spasticity and Upper Limb Function in Individuals With Stroke

Spasticity after stroke is common that affect upper limb strength and make activities of daily living difficult. There are many techniques but not any standardized technique for long term effect on reduction of spasticity and improving upper limb strength. This study aimed to explore and understand the effectiveness of neural mobilization on reduction of spasticity and improving upper limb strength in individuals with stroke. This is mixed method approach of embedded design, multicentric study recruited 7 individuals with stroke as no new themes or codes were emerging (data saturated). Median nerve mobilization was given 20 oscillations per minute for 3 times & repeated 3 times with a pause of 1 minute between each sets for 5times/week for 4weeks. Outcome measures were Modified Ashworth Scale (MAS), Brunnstrom's grading of hand recovery and Hydraulic hand dynamometer(HHD) for grip and pinch strength. Pre and post outcomes data were collected at baseline and 4weeks after intervention and in depth face to face structured interviews was conducted after 4weeks of intervention to explore the effectiveness of median nerve mobilization on reduction of spasticity and the improvement of upper limb strength.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Spasticity after stroke is common that affect upper limb strength and make activities of daily living difficult. There are many techniques but not any standardized technique for long term effect on reduction of spasticity and improving upper limb strength. This study aimed to explore and understand the effectiveness of neural mobilization on reduction of spasticity and improving upper limb strength in individuals with stroke. This is mixed method approach of embedded design, multicentric study recruited 7 individuals with stroke as no new themes or codes were emerging (data saturated). Median nerve mobilization was given 20 oscillations per minute for 3 times & repeated 3 times with a pause of 1 minute between each sets for 5times/week for 4weeks. Primary outcome measure was Modified Ashworth Scale (MAS) to assess elbow and wrist flexors spasticity and secondary outcome measures were Brunnstrom's stages for hand recovery and Hydraulic hand dynamometer(HHD) to measure grip and pinch strength. Pre and post outcomes data were collected at baseline and 4weeks after intervention and in depth face to face structured interviews was conducted after 4weeks of intervention to explore the effectiveness of median nerve mobilization on reduction of spasticity and the improvement of upper limb strength.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Haryana
      • Ambala, Haryana, India, 133207
        • Maharishi Markandeshwar Institute of Physiotherapy & Rehabilitation
      • Hisar, Haryana, India, 125001
        • Healing Hands Physiotherapy & Rehabilitation
      • Kaithal, Haryana, India, 136027
        • Bedi Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants with subacute and chronic stroke (1month and above) having upper limb spasticity.
  2. Participants with haemorrhagic and ischemic stroke.
  3. Participants who tolerate the supine position.
  4. Participants who are oriented and alert.
  5. Both males and females.
  6. Participants older than 18 years.

Exclusion Criteria:

  1. Participants with a score greater than 3 on The Modified Ashworth Scale.
  2. Participants with affected speech.
  3. Participants with upper limb deformity.
  4. Participants experiencing dizziness.
  5. Any increase in the dosage of anti-spastic medications during the intervention period.
  6. General health problems or pathologies that affect the nervous system like uncontrolled diabetes, hypertension and recent surgeries.
  7. Recent onset of worsening neurological signs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Median nerve mobilization
Experimental arm given Median nerve mobilization for 12mins 3sets for 3mins each with 1 minute interval in between for 5times a week for 4weeks
Median nerve mobilization was given 20 oscillations per minute for 3 times & repeated 3 times with a pause of 1 minute between each sets for 5times/week for 4weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale (MAS)
Time Frame: Change from baseline and 4 weeks
For spasticity, Total 4 grades are there. Grade 0 means no increase in muscle tone and grade 4 means affected part rigid in flexion or extension. More grade means more spasticity is there.
Change from baseline and 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brunnstrom's stages for hand recovery
Time Frame: Change from baseline and 4 weeks
To check recovery of hand functions. Total 7 grades are there. Increase in grade means increase in hand functions.
Change from baseline and 4 weeks
Hydraulic hand dynamometer
Time Frame: Change from baseline and 4 weeks
For grip and pinch strength
Change from baseline and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rittu Sharma, (MPT), Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
  • Study Chair: Asir John Samuel, Ph.D, Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation
  • Study Director: Akanksha Saxena, (Ph.D), Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2021

Primary Completion (Actual)

February 19, 2022

Study Completion (Actual)

March 15, 2022

Study Registration Dates

First Submitted

March 30, 2022

First Submitted That Met QC Criteria

March 30, 2022

First Posted (Actual)

April 6, 2022

Study Record Updates

Last Update Posted (Actual)

August 17, 2022

Last Update Submitted That Met QC Criteria

August 16, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Median nerve mobilization

3
Subscribe